These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3000429)

  • 21. Calmodulin antagonistic action of KS-504a, a novel metabolite of the fungus Mollisia ventosa.
    Nakanishi S; Kuroda K; Osawa K; Kase H
    Agric Biol Chem; 1990 Oct; 54(10):2697-702. PubMed ID: 1369297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of the drug-binding sites of calmodulin.
    Zimmer M; Hofmann F
    Eur J Biochem; 1987 Apr; 164(2):411-20. PubMed ID: 3032617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase.
    Ichimura M; Eiki R; Osawa K; Nakanishi S; Kase H
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):311-6. PubMed ID: 8645223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of activation of cyclic nucleotide phosphodiesterase: requirement of the binding of four Ca2+ to calmodulin for activation.
    Huang CY; Chau V; Chock PB; Wang JH; Sharma RK
    Proc Natl Acad Sci U S A; 1981 Feb; 78(2):871-4. PubMed ID: 6262778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interaction of calcium agonists and antagonists with Ca-binding proteins and their effect on cyclic nucleotide phosphodiesterase].
    Feoktistov IA; Baldenkov GN; Barannik IV; Cherviakov EB; Larionov NP
    Biokhimiia; 1990 Apr; 55(4):754-9. PubMed ID: 2165822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential inhibition of calmodulin-sensitive phosphodiesterase and Ca++-adenosine triphosphatase by chlorpromazine-linked calmodulin.
    Prozialeck WC; Wallace TL; Weiss B
    J Pharmacol Exp Ther; 1987 Oct; 243(1):171-9. PubMed ID: 2822896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calmodulin-like activity and calcium-dependent phosphodiesterase in purified cells of the rat zona glomerulosa and zona fasciculata.
    Koletsky RJ; Brown EM; Williams GH
    Endocrinology; 1983 Aug; 113(2):485-90. PubMed ID: 6307640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium-dependent and -independent interactions of the calmodulin-binding domain of cyclic nucleotide phosphodiesterase with calmodulin.
    Yuan T; Walsh MP; Sutherland C; Fabian H; Vogel HJ
    Biochemistry; 1999 Feb; 38(5):1446-55. PubMed ID: 9931009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Mg2+-binding sites and the role of Mg2+ on target recognition by calmodulin.
    Ohki S; Ikura M; Zhang M
    Biochemistry; 1997 Apr; 36(14):4309-16. PubMed ID: 9100027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium-independent bacterial activator of cyclic nucleotide phosphodiesterase and Ca2+/Mg2+-ATPase.
    Alakhov VYu ; Emelyanenko EI; Shakhparonov MI; Dudkin SM
    Biochem Biophys Res Commun; 1985 Oct; 132(2):591-7. PubMed ID: 2933039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chimeras of yeast and chicken calmodulin demonstrate differences in activation mechanisms of target enzymes.
    Nakashima K; Maekawa H; Yazawa M
    Biochemistry; 1996 Apr; 35(17):5602-10. PubMed ID: 8611552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential inhibition of calcium-dependent and calmodulin-dependent enzymes by drug-calmodulin adducts.
    Zhang SP; Prozialeck WC; Weiss B
    Mol Pharmacol; 1990 Nov; 38(5):698-704. PubMed ID: 2146488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle.
    Hagiwara M; Endo T; Hidaka H
    Biochem Pharmacol; 1984 Feb; 33(3):453-7. PubMed ID: 6322804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Active site-directed inhibition of Ca2+/calmodulin-dependent protein kinase type II by a bifunctional calmodulin-binding peptide.
    Kelly PT; Weinberger RP; Waxham MN
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):4991-5. PubMed ID: 3134656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.
    Agre P; Virshup D; Bennett V
    J Clin Invest; 1984 Sep; 74(3):812-20. PubMed ID: 6088585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation of calmodulin on Tyr99 selectively attenuates the action of calmodulin antagonists on type-I cyclic nucleotide phosphodiesterase activity.
    Saville MK; Houslay MD
    Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):863-8. PubMed ID: 8192677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calmodulin-mediated cadmium inhibition of phosphodiesterase activity, in vitro.
    Flik G; van de Winkel JG; Pärt P; Bonga SE; Lock RA
    Arch Toxicol; 1987 Feb; 59(5):353-9. PubMed ID: 3034196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of a calmodulin-sensitive cyclic nucleotide phosphodiesterase in rat parotid gland.
    Ku KY; Butcher FR
    Biochim Biophys Acta; 1980 Aug; 631(1):70-8. PubMed ID: 6249394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of calmodulin-activated smooth-muscle myosin light-chain kinase by calmodulin-binding peptides and fluorescent (phosphodiesterase-activating) calmodulin derivatives.
    Török K; Cowley DJ; Brandmeier BD; Howell S; Aitken A; Trentham DR
    Biochemistry; 1998 Apr; 37(17):6188-98. PubMed ID: 9558358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased cyclic nucleotide phosphodiesterase (PDE) and calmodulin activities in soluble fraction of Graves' thyroid: analysis of increase in Ca+2 dependence of PDE activities.
    Yagura T; Nagata I; Kuma K; Uchino H
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1180-6. PubMed ID: 2987288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.